ArticleEuropean journal of nuclear medicine and molecular imaging2024

Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy.

Conrad-Amadeus Voltin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.